Cargando…

Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes

[Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooqi, Muhammad Awais, Kang, Chul-Ung, Choi, Kyung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483668/
https://www.ncbi.nlm.nih.gov/pubmed/37692213
http://dx.doi.org/10.1021/acsomega.3c03155
_version_ 1785102430248108032
author Farooqi, Muhammad Awais
Kang, Chul-Ung
Choi, Kyung Hyun
author_facet Farooqi, Muhammad Awais
Kang, Chul-Ung
Choi, Kyung Hyun
author_sort Farooqi, Muhammad Awais
collection PubMed
description [Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro models are required to evaluate the potential benefits and toxicity of nutraceuticals. Organ-on-chip (OOC) models have emerged as a promising alternative to traditional in vitro models and animal testing due to their ability to mimic organ pathophysiology. Numerous studies have demonstrated the effectiveness of OOC models in identifying pharmaceutically relevant compounds and accurately assessing compound-induced toxicity. This review examines the utility of traditional in vitro nutraceutical testing models and discusses the potential of OOC technology as a preclinical testing tool to examine the biomedical potential of nutraceuticals by reducing the need for animal testing. Exploring the capabilities of OOC models in carrying out plant-based bioactive compounds can significantly contribute to the authentication of nutraceuticals and drug discovery and validate phytochemicals medicinal characteristics. Overall, OOC models can facilitate a more systematic and efficient assessment of nutraceutical compounds while overcoming the limitations of current traditional in vitro models.
format Online
Article
Text
id pubmed-10483668
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-104836682023-09-08 Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes Farooqi, Muhammad Awais Kang, Chul-Ung Choi, Kyung Hyun ACS Omega [Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro models are required to evaluate the potential benefits and toxicity of nutraceuticals. Organ-on-chip (OOC) models have emerged as a promising alternative to traditional in vitro models and animal testing due to their ability to mimic organ pathophysiology. Numerous studies have demonstrated the effectiveness of OOC models in identifying pharmaceutically relevant compounds and accurately assessing compound-induced toxicity. This review examines the utility of traditional in vitro nutraceutical testing models and discusses the potential of OOC technology as a preclinical testing tool to examine the biomedical potential of nutraceuticals by reducing the need for animal testing. Exploring the capabilities of OOC models in carrying out plant-based bioactive compounds can significantly contribute to the authentication of nutraceuticals and drug discovery and validate phytochemicals medicinal characteristics. Overall, OOC models can facilitate a more systematic and efficient assessment of nutraceutical compounds while overcoming the limitations of current traditional in vitro models. American Chemical Society 2023-08-21 /pmc/articles/PMC10483668/ /pubmed/37692213 http://dx.doi.org/10.1021/acsomega.3c03155 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Farooqi, Muhammad Awais
Kang, Chul-Ung
Choi, Kyung Hyun
Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title_full Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title_fullStr Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title_full_unstemmed Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title_short Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
title_sort organ-on-chip: advancing nutraceutical testing for improved health outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483668/
https://www.ncbi.nlm.nih.gov/pubmed/37692213
http://dx.doi.org/10.1021/acsomega.3c03155
work_keys_str_mv AT farooqimuhammadawais organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes
AT kangchulung organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes
AT choikyunghyun organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes